Hospital
Flagler Hospital INC
Flagler Hospital INC was paid $13.36M by Medicaid between Jan 2018 and Nov 2024, across 195 billing codes. Its largest line is 99283, emergency room visit (moderate) — 17% of everything it billed.
33Billing provider infoFLAGLER HOSPITAL INC
ST AUGUSTINE, FL 32086
ST AUGUSTINE, FL 32086
33aNPI1144211020assigned 10/31/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$13.36M
24GClaims337,568
24DCodes billed195
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in Florida
Rank by total paid#38 of 163
Median peer was paid$4.77M
This provider vs. median2.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 41,767 | $1.01M | |
| 2019 | 65,708 | $2.02M | |
| 2020 | 63,681 | $2.57M | |
| 2021 | 73,992 | $3.00M | |
| 2022 | 68,830 | $2.94M | |
| 2023 | 19,854 | $1.36M | |
| 2024incomplete | 3,736 | $449K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 17% | 16,266 | 14,971 | $2.21M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 12% | 17,540 | 15,035 | $1.57M |
| 96361 | Intravenous infusion, hydration; each additional hour | 9.9% | 5,178 | 4,561 | $1.32M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 6.8% | 8,075 | 7,499 | $902K |
| 80053 | Comprehensive metabolic panel | 4.7% | 19,836 | 15,562 | $627K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 4.4% | 2,390 | 2,100 | $593K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 3.3% | 1,732 | 1,523 | $439K |
| 70450 | Computed tomography, head or brain; without contrast material | 3.2% | 3,117 | 2,587 | $432K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 3.1% | 2,767 | 1,670 | $413K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.0% | 1,894 | 1,679 | $398K |
| 80048 | Basic metabolic panel (calcium, ionized) | 2.3% | 5,115 | 3,962 | $309K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.1% | 3,265 | 2,781 | $280K |
183 more codes
| 59025 | Fetal non-stress test | 1.5% | 2,092 | $199K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.3% | 6,718 | $180K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.2% | 22,591 | $160K |
| G0378 | Hospital observation service, per hour | 1.2% | 2,633 | $160K |
| A9270 | Non-covered item or service | 1.2% | 6,882 | $155K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,736 | $132K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 546 | $124K |
| J3490 | Unclassified drugs | <1% | 5,945 | $122K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 2,267 | $109K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 1,355 | $101K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 7,922 | $98K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 3,338 | $91K |
| 82962 | <1% | 2,926 | $89K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,626 | $79K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 2,262 | $75K |
| 85610 | <1% | 6,071 | $69K | |
| 81001 | <1% | 9,250 | $66K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 2,090 | $63K |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 3,081 | $61K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 3,199 | $59K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 8,047 | $58K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 725 | $58K |
| 71045 | Radiologic examination, chest; single view | <1% | 6,580 | $57K |
| 86403 | <1% | 1,285 | $56K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 5,054 | $56K |
| 85730 | <1% | 4,390 | $49K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,746 | $48K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 3,036 | $44K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 337 | $42K |
| 84484 | <1% | 5,212 | $42K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 866 | $40K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,729 | $35K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,488 | $35K |
| 81025 | <1% | 4,927 | $33K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 729 | $29K |
| 83690 | <1% | 4,329 | $29K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 3,562 | $29K |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 1,684 | $27K |
| 87070 | <1% | 609 | $25K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,379 | $24K |
| 73564 | <1% | 583 | $24K | |
| 84702 | <1% | 1,612 | $21K | |
| C1769 | Guide wire | <1% | 256 | $21K |
| 73630 | <1% | 621 | $21K | |
| 81003 | <1% | 2,053 | $21K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 207 | $21K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 122 | $21K |
| 84145 | <1% | 1,206 | $20K | |
| 82553 | <1% | 1,931 | $20K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 1,066 | $20K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,523 | $19K |
| 87077 | <1% | 1,660 | $19K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,594 | $19K |
| 80047 | <1% | 417 | $18K | |
| 83880 | <1% | 1,569 | $18K | |
| 82803 | <1% | 1,898 | $17K | |
| 83735 | <1% | 3,405 | $17K | |
| 82565 | <1% | 323 | $16K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 1,056 | $16K |
| 73610 | <1% | 366 | $16K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,483 | $15K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 935 | $15K |
| 85027 | <1% | 3,182 | $15K | |
| 83605 | <1% | 1,971 | $15K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 328 | $14K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 1,216 | $13K |
| 76830 | Ultrasound, transvaginal | <1% | 361 | $13K |
| 80076 | <1% | 879 | $13K | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 519 | $13K |
| 76775 | <1% | 272 | $13K | |
| 74018 | <1% | 463 | $12K | |
| 86140 | <1% | 2,614 | $11K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 75 | $11K |
| 73130 | <1% | 308 | $11K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 112 | $10K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 549 | $10K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 4,656 | $9K |
| 85379 | <1% | 1,125 | $9K | |
| 73030 | <1% | 342 | $9K | |
| 80061 | Lipid panel | <1% | 3,954 | $8K |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,705 | $8K |
| J2704 | Injection, propofol, 10 mg | <1% | 708 | $8K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 987 | $7K |
| 93971 | <1% | 244 | $7K | |
| 87186 | <1% | 1,452 | $7K | |
| 87040 | <1% | 1,045 | $7K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 70 | $7K |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 713 | $6K |
| 99223 | Prolong inpt eval add15 m | <1% | 62 | $6K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 315 | $6K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 395 | $5K |
| 86592 | <1% | 817 | $5K | |
| 84439 | <1% | 1,257 | $5K | |
| 72100 | <1% | 282 | $5K | |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | <1% | 181 | $5K |
| 86900 | <1% | 1,927 | $5K | |
| 71250 | <1% | 165 | $5K | |
| 81002 | <1% | 208 | $5K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 412 | $5K |
| 86901 | <1% | 1,926 | $5K | |
| 10060 | <1% | 39 | $5K | |
| 76642 | <1% | 74 | $4K | |
| 12001 | <1% | 109 | $4K | |
| 85652 | <1% | 1,198 | $4K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 268 | $4K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 961 | $4K |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | <1% | 58 | $4K |
| 86885 | <1% | 1,060 | $4K | |
| 82550 | <1% | 657 | $4K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 27 | $3K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,621 | $3K |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 586 | $3K |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 226 | $3K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 178 | $3K |
| 82947 | <1% | 170 | $3K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 473 | $3K |
| 84100 | <1% | 906 | $3K | |
| 93458 | <1% | 12 | $3K | |
| 96376 | <1% | 789 | $2K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 248 | $2K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 332 | $2K |
| 86850 | <1% | 919 | $2K | |
| 86762 | <1% | 62 | $2K | |
| 82728 | <1% | 1,005 | $2K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 504 | $2K |
| 85007 | <1% | 242 | $2K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 49 | $2K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 14 | $2K |
| 87205 | <1% | 289 | $2K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,015 | $2K |
| 87210 | <1% | 238 | $2K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 31 | $2K |
| 73502 | <1% | 160 | $1K | |
| 82077 | <1% | 481 | $1K | |
| J0360 | Injection, hydralazine hcl, up to 20 mg | <1% | 12 | $1K |
| 73110 | <1% | 63 | $1K | |
| 12011 | <1% | 28 | $994.08 | |
| 87081 | <1% | 1,120 | $945.45 | |
| 83540 | <1% | 1,012 | $941.41 | |
| 87807 | <1% | 174 | $932.54 | |
| 72170 | <1% | 33 | $929.60 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 13 | $866.47 |
| 99070 | <1% | 13 | $836.52 | |
| J2791 | Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu | <1% | 34 | $833.36 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 602 | $801.49 |
| 29530 | <1% | 24 | $764.32 | |
| 82607 | <1% | 563 | $729.66 | |
| 83550 | <1% | 867 | $696.72 | |
| 87340 | <1% | 787 | $665.31 | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 57 | $624.18 |
| 85018 | <1% | 158 | $622.75 | |
| 80320 | <1% | 179 | $563.29 | |
| 85014 | <1% | 80 | $548.13 | |
| 84436 | <1% | 180 | $493.20 | |
| 96367 | <1% | 18 | $447.35 | |
| 84550 | <1% | 458 | $393.18 | |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | <1% | 15 | $392.42 |
| 93017 | <1% | 15 | $236.71 | |
| 86803 | <1% | 146 | $163.19 | |
| 90715 | <1% | 48 | $146.32 | |
| 94760 | <1% | 20 | $90.00 | |
| 84156 | <1% | 79 | $70.29 | |
| 83655 | <1% | 16 | $55.64 | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 33 | $45.22 |
| 82150 | <1% | 15 | $33.00 | |
| 82746 | <1% | 12 | $32.78 | |
| 82570 | <1% | 34 | $27.00 | |
| 82043 | <1% | 206 | $15.19 | |
| 80143 | <1% | 53 | $11.97 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 36 | $10.79 |
| 84479 | <1% | 29 | $7.51 | |
| 80179 | <1% | 25 | $5.98 | |
| 84703 | <1% | 13 | $2.33 | |
| J3480 | Injection, potassium chloride, per 2 meq | 0% | 23 | $0.00 |
| 86060 | 0% | 17 | $0.00 | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 0% | 16 | $0.00 |
| J1815 | Injection, insulin, per 5 units | 0% | 28 | $0.00 |
| J2790 | Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.) | 0% | 17 | $0.00 |
| 80329 | 0% | 16 | $0.00 | |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 21 | $0.00 |
| 73080 | 0% | 15 | $0.00 | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | 0% | 20 | $0.00 |
| 31720 | 0% | 22 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDEVOOGHT, CARLTON (EVP/CHIEF ADMIN OFFICER)